4 Cancer Treatment related Patents Granted in the past 10 months. Fast track! Pay the $50 and know what others now know! https://adisinsight.springer.com/drugs/800045610 10 Mar 2022 NR2F6 receptor modulators are still in preclinical development stage for Cancer and Autoimmune disorders in USA New Molecular Entity Yes Available For Licensing Yes